Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Lymphoma
×
eribulin
×
Clear all
Filters
3
NCT02082626
2020-03-10
ERIBULIN
University of Oklahoma
Phase 1
Terminated
3 enrolled
NCT02171260
2019-01-15
BOLD 113
Eisai Inc.
Phase 1
Completed
23 enrolled
22 charts